30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Vexim

€2.8MM, (~US $3.7MM), +91%

  • >2,000 SpineJack implants sold in quarter; >12,600 sold since 2010 introduction